Prognostic Nomogram for Overall Survival in Stage IIB-IVA Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy
Am J Obstet Gynecol. 2010 Feb 1;202(2), J-Y Tseng, M-S Yen, N-F Twu, C-R Lai, H-C Horng, C-C Tseng, K-C Chao, C-M Juang
ABSTRACT
Objective: On the basis of outcome data from concurrent chemoradiotherapy (CCRT) for locally advanced cervical squamous cell carcinoma, the authors developed a nomogram for predicting survival outcome.
Study Design: Two hundred fifty-one eligible patients with International Federation of Gynecology and Obstetrics stage IIB-IVA squamous cell carcinoma of the uterine cervix who underwent CCRT were included for the construction of the nomogram. Predictor variables included age, serum squamous cell carcinoma antigen, tumor size, parametrium invasion, hydronephrosis, bladder/rectum invasion, and lymph node metastases. Internal validation of the nomogram was performed.
Results: A nomogram for predicting the 5 year overall survival for these patients was constructed on the basis of a Cox regression model from 7 parameters. The concordance index was 0.69.
Conclusion: This nomogram is a predictive tool, upon external validation, that can be used to counsel patients in predicting outcomes. The discriminatory ability of the nomogram indicates that this population should not be considered homogeneous with respect to risk of death.
